Literature DB >> 11976590

[Alzheimer's disease: a public health problem: yes, but a priority?].

J F Dartigues1, C Helmer, B Dubois, C Duyckaerts, B Laurent, F Pasquier, J Touchon.   

Abstract

Alzheimer's Disease is a major Public Health problem for many reasons. First, it is a frequent disease since, in France, the prevalence was estimated at about 400.000 cases, and the annual incidence at 100.000 cases. The frequency of the disease increases, in particular due to the ageing of the population. This disease has major consequences on the life of the patient and his/her caretaker. The cost of the disease is important, estimated at about 50 milliards of French francs. Pharmaceutical treatment and other interventions are possible in particular to delay the nursing home placement. On the other hand, this disease is often ignored, under-diagnosed, underestimated and exposed to inequality in resorting to care. In summary, Alzheimer's Disease (AD) has all the criteria required for a major public health problem. In spite of this observation, AD is not yet considered as a priority for health authorities, although attitudes are changing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976590

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  2 in total

1.  Socio-cultural adaptation and standardization of Dubois' five words testing in a population of normal subject in Mali, West Africa.

Authors:  Cheick O Guinto; Toumany Coulibaly; Zeinab Koné; Souleymane Coulibaly; Boubacar Maiga; Kekouta Dembélé; Lassana Cissé; Mamadou Konaté; Thomas Coulibaly; Adama S Sissoko; Mamadou Karambé; Barrington Burnett; Guida Landouré; Moussa Traoré
Journal:  eNeurologicalSci       Date:  2016-02-10

2.  [Five-word test calibration in a Tunisian population of healthy subjects].

Authors:  Nadia Bouattour; Nouha Farhat; Hanen Hadjkacem; Olfa Hdiji; Salma Sakka; Mariem Dammak; Chokri Mhiri
Journal:  Pan Afr Med J       Date:  2019-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.